You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Daclizumab for relapsing remitting multiple sclerosis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2012
|
| DOI | 10.1002/14651858.cd008127.pub3 |
| Pubmed ID | |
| Authors |
Liu J, Wang L, Zhan SY, Xia Y |
| Abstract |
The anti-CD25 treatment of daclizumab appears to be effective in patients with relapsing remitting multiple sclerosis (RRMS) as regards clinical and MRI outcomes. Moreover, there are no severe safety concerns arising from clinical testing so far. |
Mendeley readers
The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 8% |
| Unknown | 12 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 3 | 23% |
| Professor | 2 | 15% |
| Student > Ph. D. Student | 2 | 15% |
| Student > Master | 2 | 15% |
| Other | 1 | 8% |
| Other | 3 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 62% |
| Agricultural and Biological Sciences | 1 | 8% |
| Neuroscience | 1 | 8% |
| Social Sciences | 1 | 8% |
| Unknown | 2 | 15% |